DOI QR코드

DOI QR Code

Tumoral calcinosis and calciphylaxis treated with subtotal parathyroidectomy and sodium thiosulphate

  • Cho, Hyunjeong (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Yi, Yongjin (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kang, Eunjeong (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Park, Seokwoo (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Cho, Eun Jin (Department of Internal Medicine, Hongseong Medical Center) ;
  • Cho, Sung Tae (Dr. Chun & Cho's Medical Clinic & Dialysis Center) ;
  • Chun, Rho Won (Dr. Chun & Cho's Medical Clinic & Dialysis Center) ;
  • Lee, Kyu Eun (Department of Surgery, Seoul National University College of Medicine) ;
  • Oh, Kook-Hwan (Department of Internal Medicine, Seoul National University College of Medicine)
  • 투고 : 2015.06.30
  • 심사 : 2015.08.28
  • 발행 : 2016.06.30

초록

Tumoral calcinosis (TC) is a condition resulting from extensive calcium phosphate precipitation, primarily in the periarticular tissues around major joints. Calciphylaxis is a fatal ischemic vasculopathy mainly affecting dermal blood vessels and subcutaneous fat. This syndrome is rare and predominantly occurs in patients with end-stage renal disease. Here, we report on a rare case involving a patient with TC complicated with calciphylaxis. Our patient was a 31-year-old man undergoing hemodialysis who presented with masses on both shoulders and necrotic cutaneous ulcers, which were associated with secondary hyperparathyroidism, on his lower legs. He underwent subtotal parathyroidectomy, and sodium thiosulfate (STS) was administered for 27 weeks. Twenty months after beginning the STS treatment course, he experienced dramatic relief of his TC and calciphylaxis.

키워드

참고문헌

  1. Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E. Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol 2011;65:1-12. https://doi.org/10.1016/j.jaad.2010.08.038
  2. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002;61:2210-7.
  3. Hafner J, Keusch G, Wahl C, Sauter B, Hurlimann A, von Weizsacker F, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995;33:954-62. https://doi.org/10.1016/0190-9622(95)90286-4
  4. Bardsley S, Coutts R, Wilson C. Calciphylaxis and its surgical significance. ANZ J Surg 2005;75:356-9. https://doi.org/10.1111/j.1445-2197.2005.03354.x
  5. Katikaneni M, Lwin L, Villanueva H, Yoo J. Calciphylaxis and subtotal parathyroidectomy: a double-edged sword. Hemodial Int 2013;17(Suppl 1):S33-6. https://doi.org/10.1111/hdi.12087
  6. Oliveira TM, Frazao JM. Calciphylaxis: from the disease to the diseased. J Nephrol 2015;28:531-40. https://doi.org/10.1007/s40620-015-0192-2
  7. Rodriguez-Villarreal I, Callejas R, Sanchez M, Laso N, Gallar P, Ortega O, et al. Calcifilaxis o arteriolopatia uremica calcificante: combinaciín de tratamientos. NefroPlus 2010;3:39-44.
  8. Magro CM, Simman R, Jackson S. Calciphylaxis: a review. J Am Col Certif Wound Spec 2011;2:66-72.
  9. Yatzidis H, Agroyannis B. Sodium thiosulfate treatment of soft-tissue calcifications in patients with end-stage renal disease. Perit Dial Int 1987;7:250-2.
  10. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004;43:1104-8.